Association between sarcopenic obesity and type 2 diabetes, hypertension as well as dyslipidemia in overweight and obese adults

  Objective  To assess the prevalence of sarcopenic obesity(SO) in overweight and obese adults and the its association with type 2 diabetes, hypertension, and dyslipidemia.

  Methods  The clinical data of 156 overweight and obese adults and 46 normal-weight participants of similar age in our hospital were retrospectively analyzed. The measurements of anthropometry, blood biochemical metabolism, body composition assessment were performed. The overweight and obese patients were then divided into SO group or non-SO group. The general data of two groups were analyzed, and Logistic regression analysis was used to analyze the association between SO and type 2 diabetes, hypertension, dyslipidemia.

  Results  Of 156 overweight or obese participants, 23(14.74%) met the criteria of SO, who had a higher incidence of type 2 diabetes, hypertension, and dyslipidemia than those without SO. Logistic regression analysis showed that ratios of type 2 diabetes, hypertension and dyslipidemia were 344.20%, 302.20% and 515.60%, respectively, in SO patients, when compared to those without SO. After adjusting for age, gender, marriage and smoking, the ratios were 344.20%, 298.30% and 510.50%, respectively.

  Conclusions  SO seems to be strongly associated with type 2 diabetes, hypertension, and dyslipidemia. Therefore, it is clinically useful to screen SO in this population.